Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.59 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4743773 | 0.89 | FTO (0.60) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL2314510 | 0.89 | FTO (0.60) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL84112 | 0.88 | FTO (0.59) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL2184643 | 0.88 | FTO (0.59) | FTOMAPTHPGDMEN1HTT | |
| Hydrochloric Acid SCHEMBL7640824 | 0.86 | FTO (0.57) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL22110384 | 0.85 | FTO (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL1115891 | 0.85 | HPGD (0.57) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL4825622 | 0.85 | FTO (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL7647553 | 0.85 | FTO (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL1669688 | 0.84 | HPGD (0.59) | FTOMAPTHPGDMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2975406-B1 | PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | ENZO LIFE SCIENCES INC (US) | 2018-07-18 | — | — | EP | claimed |
| EP-2975405-B1 | PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | ENZO LIFE SCIENCES INC (US) | 2018-03-07 | — | — | EP | claimed |
| EP-2975405-A1 | PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | Enzo Life Sciences, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| EP-2975406-A1 | PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | Enzo Life Sciences, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| EP-2567233-B1 | PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | ENZO LIFE SCIENCES INC (US) | 2015-11-04 | — | — | EP | claimed |
| US-9097673-B2 | Processes and kits for determining multi-drug resistance of cells | ENZO LIFE SCIENCES, INC. (US) | 2015-08-04 | — | — | US | claimed |
| US-20130323773-A1 | PROCESSES AND KITS FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | ENZO LIFE SCIENCES, INC. | 2013-12-05 | — | — | US | claimed |
| US-8445271-B2 | Processes and kits for determining multi-drug resistance of cells | ENZO LIFE SCIENCES, INC. (US) | 2013-05-21 | — | — | US | claimed |
| EP-2567233-A1 | PROCESSES AND KITS FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | Enzo Life Sciences, Inc. (US) | 2013-03-13 | — | — | EP | claimed |
| US-8097404-B2 | Composition and method for cell permeabilization comprising N-octyl-β-D-glucopyranoside, sodium polyphosphates, rubidium chloride and/or lithium chloride for detecting living cells on a membrane | MILLIPORE CORPORATION (US) | 2012-01-17 | — | — | US | claimed |
| WO-2011139634-A1 | PROCESSES AND KITS FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS | ENZO LIFE SCIENCES, INC. (US) | 2011-11-10 | — | — | WO | claimed |
| US-20110269168-A1 | Processes and kits for determining multi-drug resistance of cells | ENZO LIFE SCIENCES, INC. | 2011-11-03 | — | — | US | claimed |
| EP-2107119-B1 | Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane | MILLIPORE CORP (US) | 2010-05-12 | — | — | EP | claimed |
| EP-2107119-A1 | Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane | Millipore Corporation (US) | 2009-10-07 | — | — | EP | claimed |
| US-20090246822-A1 | Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane | EMD MILLIPORE CORPORATION | 2009-10-01 | — | — | US | claimed |
| US-20030018457-A1 | Biological modeling utilizing image data | BIOANALYTICS GROUP, L.L.C., THE | 2003-01-23 | — | — | US | claimed |
| WO-2002099736-A1 | BIOLOGICAL MODELING UTILIZING IMAGE DATA | PHYSIOME SCIENCES, INC. (US) | 2002-12-12 | — | — | WO | claimed |
| EP-3548006-B1 | COMPOSITION FOR USE IN THE TREATMENT OF INTESTINAL ALTERATIONS | ALFASIGMA SPA (IT) | 2023-11-15 | — | — | EP | disclosed |
| EP-0603266-A1 | USE OF HALOALKYL DERIVATIVES OF REPORTER MOLECULES TO ANALYZE METABOLIC ACTIVITY IN CELLS | MOLECULAR PROBES, INC. (US) | 1994-06-29 | — | — | EP | disclosed |
| WO-1993004192-A1 | USE OF HALOALKYL DERIVATIVES OF REPORTER MOLECULES TO ANALYZE METABOLIC ACTIVITY IN CELLS | MOLECULAR PROBES, INC. (US) | 1993-03-04 | — | — | WO | disclosed |